LCT files patent for cannabinoid combination drug candidate for dementia – Nokturnal
Melbourne-headquarters Living Cell Technologies (ASX: LCT) has filed a new provisional patent application over a combination drug candidate, which includes cannabidiol (CBD) and another off-patent pharmaceutical ingredient, and its use in the treatment of dementia. The filing of a provisional patent application establishes the priority date of the invention ahead of potential competitor companies. The … Read more